论文信息 - Combined Blockade of CD47-Sirpa Interaction By 5F9 (Magrolimab) and Azacitidine/Venetoclax Therapy Facilitates Macrophage-Mediated Anti-Leukemia Efficacy in AML Pre-Clinical Models - 字舞流文

Combined Blockade of CD47-Sirpa Interaction By 5F9 (Magrolimab) and Azacitidine/Venetoclax Therapy Facilitates Macrophage-Mediated Anti-Leukemia Efficacy in AML Pre-Clinical Models

M. Konopleva | M. Andreeff | N. Daver | Weiguo Zhang | Qi Zhang | M. Chao | R. Maute | Shelley M Herbrich | Yannan Jia | Y. Nishida | Cassandra L. Ramage | Connie Weng